NL-OMON35904已完成不适用
The pharmacokinetic effect of clarithromycin on the AUC0-12h of linezolid in multidrug-resistant and extensively drug-resistant tuberculosis patients - LIN/CLA interaction study in MDR/XDR-TB patients
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 7
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Age >=18 years old
- •- Signed informed consent
- •- Diagnosis of MDR-TB confirmed with standard microbiological criteria (culture-based, molecular or both)
排除标准
- •The criteria for exclusion are based on the contra indication as mentioned in the SPC texts of LIN and CLA.
- •- Hypersensitivity to: linezolid, clarithromycin, erythromycin, or any macrolide antibiotics, or any of the excipients of linezolid or clarithromycin.
- •- Concomitant use with astemizole, cisapride, ergotamine derivatives (dihydroergotamine, ergotamine), monoamine oxidase inhibitors (phenelzine, isocarboxazid, selegiline, or moclobemide), pimozide, or terfenadine.
- •- Pregnancy or breast-feeding.
- •- Hypokalemia
- •- Concomitant use of other P-glycoprotein inhibitors/inducers, e.g. amiodarone, verapamil, digoxin, tipranavir/ritonavir, lovastatin, tariquidar, itraconazole, dipyridamol, erythromycin, ritonavir, quinidine.
- •A pharmacist will check the co-medication of each patient for drug-drug interactions.
研究者
相似试验
进行中（未招募）
不适用
The effect of combining two anti-tuberculosis drugs, clarithromycin and linezolid, on the amount of clarithromycin and linezolid in the blood of severe tuberculosis patients.Multidrug-resistant and extensively drug-resistant tubeculosis (MDR/XDR-TB)MedDRA version: 14.0Level: LLTClassification code 10043148Term: TBSystem Organ Class: 10021881 - Infections and infestationsEUCTR2011-000513-39-NLniversity Medical Center Groningen8
招募中
不适用
inezolid and clarithromycin drug-interaction study in multidrug-resistant and extensively drug-resistant tuberculosis patients.-'drug interaction'- linezolid- clarithromycin- multidrug-resistant and extensively drug-resistant tuberculosis (MDR/XDR-TB)in dutch/ in het nederlands:- geneesmiddelinteractie- linezolid- claritromycine- multidrug-resistente and extensieve drug-resistente tuberculose (MDR/XDR-TBC)NL-OMON24566niversity Medical Center GroningenA.t.t.n. Prof Dr JGW Kosterink, Department of Hospital and Clinical PharmacyP.O. Box 30.001; 9700 RB Groningen,The NetherlandsTel: +31 50 361 4071Fax: +31 50 361 4087Email: j.g.w.kosterink@umcg.nl7
已完成
Unknown
Therapeutic Effects of Clarithromycin and Molnupiravir in Management of COVID-19 PatientsJPRN-UMIN000048841Daido Central Hospital119
已完成
1 期
Effect of Clarithromycin on the Pharmacokinetics of Apixaban in Healthy ParticipantsVenous ThromboembolismNCT02912234Bristol-Myers Squibb20
已完成
不适用
Effect of long-term clarithromycin antibiotic therapy on preventation of pneumonia in the elderly: a prospective randomised controlled trial.pneumoniaJPRN-UMIN000023355Department of Respiratory Medicine and Infectious Diseases, Oita University Faculty of Medicine200